Barclays analyst Matt Miksic maintained a Hold rating on Johnson & Johnson today and set a price target of $234.00. According to TipRanks, Miksic i......

Market volatility has defined 2026 so far, with geopolitical tensions driving swings across the broader market. While the S&P 500 ($SPX) is down ab......

Erste Group analyst Hans Engel maintained a Buy rating on Johnson & Johnson yesterday. The company’s shares closed yesterday at $243.04. Engel cove......

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Johnson & Johnson (JNJ) and BioNano Genomics (BNGO). Johnson & Jo......

For investors aiming to grow their capital while markets remain unsettled by the worsening conflict in the Middle East, exchange-traded funds prese......

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Incyte (INCY), Sanofi (SNYNF) and Johnson & Johnso......

As investors continue to grapple with volatility amid geopolitical tensions, exchange-traded funds (ETFs) could be an attractive investment opportu......

Specialization can lead to big gains. ...

Although the ongoing conflict in the Middle East has left investors on constant alert, exchange-traded funds remain among the strongest tools to de......

This article spotlights three ETFs with Outperform ratings and significant upsides, as flagged by TipRanks’ AI analysts. ...